Filtered By:
Condition: Heart Failure
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 576 results found since Jan 2013.
Will Phase Space Tomography Revolutionize Cardiac Diagnostics? Interview with Don Crawford, CEO of Analytics 4 Life
Caution – Investigational Device. Limited by Federal Law to Investigational Use. CorVista™ is not available for commercial distribution.
Human body emits all kinds of signals that, if analyzed with the proper sensors and computers, can help u...
Source: Medgadget - October 30, 2017 Category: Medical Devices Authors: Editors Tags: Cardiology Exclusive Radiology Source Type: blogs
Cardiology MCQ Test 6
Time limit: 0
Quiz-summary
0 of 20 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Information
This test series requires login for attempting. You can login easily with your Facebook account (Use the CONNECT WITH icon on the upper part of right sidebar displaying t...
Source: Cardiophile MD - October 27, 2017 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs
How does SGLT2 inhibition improve heart failure?
How does Sodium Glucose Cotransporter-2 (SGLT2) inhibition improve heart failure?
Different ways by which SGLT2 inhibition can improve heart failure are:
Natriuresis
Osmotic diuresis
These in turn leads to reduction of plasma volume and preload. An associated decrease in blood pressure, after load and arterial stiffness follows. Reduction in afterload can improve subendocardial blood flow as well.
SGLT2 inhibitors are a new class of oral hypoglycemic agents. EMPA-REG OUTCOME trial with Empagliflozin (Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) and CANVAS trial (Canagliflozin Cardiovascular As...
Source: Cardiophile MD - October 27, 2017 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs
Cardiology MCQ Test 5
Time limit: 0
Quiz-summary
0 of 20 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Information
This test series requires login for attempting. You can login easily with your Facebook account (Use the CONNECT WITH icon on the upper part of right sidebar displaying t...
Source: Cardiophile MD - October 22, 2017 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs
Cardiology MCQ Test 3
Time limit: 0
Quiz-summary
0 of 20 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Information
This test series requires login for attempting. You can login easily with your Facebook account (Use the CONNECT WITH icon on the upper part of right sidebar displaying t...
Source: Cardiophile MD - October 20, 2017 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs
Cardiology MCQ Test 2
Time limit: 0
Quiz-summary
0 of 20 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Information
This test series requires login for attempting. You can login easily with your Facebook account (Use the CONNECT WITH icon on the upper part of right sidebar displaying t...
Source: Cardiophile MD - October 19, 2017 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs
Proprotein convertase subtilisin/kexin type 9 (PCSK9) – Cardiology MCQ – Answer
Correct answer:
Secreted into plasma by kidney
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is secreted into plasma by liver and not the kidney. Binding of PCSK9 to LDL receptors on hepatocytes enhances degradation of the LDL receptors by endosomes. This in turn leads to reduced LDL clearance. Inhibition of PCSK9 with monoclonal antibodies reduce atherosclerosis and cardiovascular events. Read more on PCSK9 inhibitors…
Reference
Bayes-Genis A et al. The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure. BIOSTAT-CHF Subanalysis. J Am Coll Cardiol. 2017; 70:2128-36.
Back to question
Source: Cardiophile MD - October 18, 2017 Category: Cardiology Authors: Johnson Francis Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
Valuing Value-Based Payment
By ANISH KOKA, MD
The idea that payment should be linked to the value lies at the heart of most of the transactions we participate in on a daily basis. Yet, value based payment in healthcare has seemingly run into very rocky waters as of late. It is at this precarious time that stakeholders representing large employers and other purchasers of health care’ took to the Harvard Business Review to write in defense of value based payment reform. The authors pepper their article with cherry picked ‘successes’ of the value movement and urge the country to forge ahead on the current path. The picture that c...
Source: The Health Care Blog - October 16, 2017 Category: Consumer Health News Authors: anish_koka Tags: Uncategorized Value-Based Payment Source Type: blogs
Intravenous ferric carboxymaltose improves peak VO2 in heart failure – EFFECT-HF study
Functional iron deficiency is present in about half of heart failure patients and is associated with poorer effort tolerance and higher mortality. Abnormal iron hemostasis in heart failure is mediated by the effect of proinflammatory cytokines on hepcidin, an important iron regulatory protein. Increase in hepcidin is responsible for the functional iron defiency due to decreased iron absorption, reduced bioavailability of iron for erythropoiesis and increased iron stores in non erythrocyte cell types [1]. Veldhuisen and colleagues in an article published in Circulation [2] with acronym EFFECT-HF study evaluated the effe...
Source: Cardiophile MD - October 15, 2017 Category: Cardiology Authors: Johnson Francis Tags: Cardiology EFFECT-HF Study Ferric carboxymaltose and heart intravenous iron in heart failure Source Type: blogs
Multiple arterial grafts give better long term results – Canadian study
(Representative image of multiple arterial revascularization)
A Canadian study [1] published in JAMA Cardiology has shown lower long term mortality, repeat revascularization, myocardial infarction and heart failure in patients receiving multiple arterial grafts as compared to those single LIMA (left internal mammary artery) graft along with SVG (saphenous vein grafts). Of over twenty thousand patients with triple vessel or left main disease who underwent CABG (coronary artery bypass graft), about 5600 received multiple arterial grafts and around 14500 received LIMA graft along with SVG. Subgroup analyses showed that the ...
Source: Cardiophile MD - October 12, 2017 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology CABG coronary artery bypass graft Coronary artery bypass grafting left main disease LIMA LITA RIMA RITA triple vessel disease Source Type: blogs
Medtronic ’s HeartWare HVAD Heart Pump Approved for Rest of Life Use
Medtronic‘s HeartWare HVAD system, a left ventricular assist device, has been approved by the FDA as a “destination therapy” for those with advanced heart failure that cannot receive a transplanted heart. The HeartWare HVAD heart pu...
Source: Medgadget - September 29, 2017 Category: Medical Devices Authors: Editors Tags: Cardiac Surgery Cardiology Critical Care Source Type: blogs
Boston Scientific ’s Resonate Cardiac Implants with HeartLogic Predict Adverse Events, Now FDA Approved
Boston Scientific won approval from the FDA and is launching its Resonate line of implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D). The implants include the firm’s HeartLogic diagnost...
Source: Medgadget - September 27, 2017 Category: Medical Devices Authors: Editors Tags: Cardiology Medicine Source Type: blogs
Abiomed ’s Impella RP First Percutaneous Heart Pump Indicated for Right Heart Failure
Abiomed won FDA approval for its Impella RP heart pump, the first percutaneous temporary ventricular support device indicated for right heart failure. The device moves blood from the inferior vena cava into the pulmonary artery, doing the work of th...
Source: Medgadget - September 25, 2017 Category: Medical Devices Authors: Editors Tags: Cardiac Surgery Cardiology Source Type: blogs
Clinical registry solution market heads toward $2 billion
Specialty medical societies such as the American College of Cardiology and American College of Surgeons sponsor clinical registries that collect observational data on patients with specific conditions or procedures, such as heart failure or joint replacement. This “real world” evidence helps hospitals improve quality of care, meet state and federal reporting requirements, and achieve pay-for-performance bonuses.
Q-Centrix, which provides technology and services that enable hospitals to participate in registries, commissioned Health Business Group to conduct a market sizing and growth study. We found that the ma...
Source: Health Business Blog - September 20, 2017 Category: Health Management Authors: dewe67 Tags: Announcements Hospitals Research clinical registries Q-Centrix Source Type: blogs
Improving drug adherence will take more than money and technology
I recently asked, “Who’s to blame?” for patients not taking their medications and cited a couple of papers describing the poor state of medication adherence. I concluded nonadherence was a huge problem, and doctors failing to educate their patients was not a major cause.
To support my contention that physicians are not the reason why patients do not take their medications as ordered I submit the following new information.
A randomized clinical trial published online in JAMA Internal Medicine looked at patients who had been discharged after myocardial infarction and prescribed drugs known to decrease the incidenc...
Source: Kevin, M.D. - Medical Weblog - September 16, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/skeptical-scalpel" rel="tag" > Skeptical Scalpel, MD < /a > Tags: Meds Cardiology Medications Primary Care Source Type: blogs
